KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →

Uncategorized

The Annals rips a commercially-sponsored study a new one

The trial showed the benefits of the diabetes drug Byetta. The accompanying editorial is not kind.

Share this articleLinkedInFacebookXEmail

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.